Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jabrane-Ferrat

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Molecular and Cellular Biology|November 1, 1994
Ets-1 activates the DRA promoter in B cellsN Jabrane-Ferrat, B M Peterlin
Molecular and Cellular Biology|May 29, 2000
Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complexN Nekrep, N Jabrane-Ferrat, B M Peterlin
Journal of Molecular Biology|July 18, 1997
Assembly of functional regulatory complexes on MHC class II promoters in vivoJ D Fontes, N Jabrane-Ferrat, B M Peterlin
Immunogenetics|January 1, 1996
The function of the octamer-binding site in the DRA promoterC F Voliva, N Jabrane-Ferrat, B M Peterlin
Biochemistry|August 10, 2000
Inhibition of expression of the type I G protein-coupled receptor for vasoactive intestinal peptide (VPAC1) by hammerhead ribozymesN Jabrane-Ferrat, A S Pollock, E J Goetzl
Molecular and Cellular Biology|July 21, 2001
Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndromeN Nekrep, M Geyer, N Jabrane-Ferrat, et al.
Current Topics in Microbiology and Immunology|February 17, 2006
Expression of MHC II genesG Drozina, J Kohoutek, N Jabrane-Ferrat, et al.
Molecular and Cellular Biology|September 1, 1996
Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactionsN Jabrane-Ferrat, J D Fontes, J M Boss, et al.
The Journal of Experimental Medicine|June 1, 1996
Binding and cooperative interactions between two B cell-specific transcriptional coactivatorsJ D Fontes, N Jabrane-Ferrat, C R Toth, et al.
Cancer Gene Therapy|July 15, 2006
Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic miceN Jabrane-Ferrat, M J Campbell, L J Esserman, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Biology|November 1, 1994
Ets-1 activates the DRA promoter in B cellsN Jabrane-Ferrat, B M Peterlin
Molecular and Cellular Biology|May 29, 2000
Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complexN Nekrep, N Jabrane-Ferrat, B M Peterlin
Journal of Molecular Biology|July 18, 1997
Assembly of functional regulatory complexes on MHC class II promoters in vivoJ D Fontes, N Jabrane-Ferrat, B M Peterlin
Immunogenetics|January 1, 1996
The function of the octamer-binding site in the DRA promoterC F Voliva, N Jabrane-Ferrat, B M Peterlin
Biochemistry|August 10, 2000
Inhibition of expression of the type I G protein-coupled receptor for vasoactive intestinal peptide (VPAC1) by hammerhead ribozymesN Jabrane-Ferrat, A S Pollock, E J Goetzl
Molecular and Cellular Biology|July 21, 2001
Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndromeN Nekrep, M Geyer, N Jabrane-Ferrat, et al.
Current Topics in Microbiology and Immunology|February 17, 2006
Expression of MHC II genesG Drozina, J Kohoutek, N Jabrane-Ferrat, et al.
Molecular and Cellular Biology|September 1, 1996
Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactionsN Jabrane-Ferrat, J D Fontes, J M Boss, et al.
The Journal of Experimental Medicine|June 1, 1996
Binding and cooperative interactions between two B cell-specific transcriptional coactivatorsJ D Fontes, N Jabrane-Ferrat, C R Toth, et al.
Cancer Gene Therapy|July 15, 2006
Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic miceN Jabrane-Ferrat, M J Campbell, L J Esserman, et al.
Pageof 2